Literature DB >> 23032308

Integrated signaling in developing lymphocytes: the role of DNA damage responses.

Jeffrey J Bednarski1, Barry P Sleckman.   

Abstract

Lymphocyte development occurs in a stepwise progression through distinct developmental stages. This ordered maturation ensures that cells express a single, non-autoreactive antigen receptor, which is the cornerstone of a diverse adaptive immune response. Expression of a mature antigen receptor requires assembly of the antigen receptor genes by the process of V(D)J recombination, a reaction that joins distant gene segments through DNA double-strand break (DSB) intermediates. These physiologic DSBs are generated by the recombinase-activating gene (RAG) -1 and -2 proteins, and their generation is regulated by lymphocyte and developmental stage-specific signals from cytokine receptors and antigen receptor chains. Collectively, these signals ensure that V(D)J recombination of specific antigen receptor genes occurs at discrete developmental stages. Once generated, RAG-induced DSBs activate the ataxia-telangiectasia mutated (ATM) kinase to orchestrate a multifaceted DNA damage response that ensures proper DSB repair. In response to RAG DSBs, ATM also regulates a cell type-specific transcriptional response, and here we discuss how this genetic program integrates with other cellular cues to regulate lymphocyte development.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23032308      PMCID: PMC3524208          DOI: 10.4161/cc.22021

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  78 in total

Review 1.  B-cell-receptor-dependent positive and negative selection in immature B cells.

Authors:  D Nemazee; V Kouskoff; M Hertz; J Lang; D Melamed; K Pape; M Retter
Journal:  Curr Top Microbiol Immunol       Date:  2000       Impact factor: 4.291

2.  B-cell differentiation stimulated by physiologic DNA double strand breaks.

Authors:  Nicole C Walsh; Michael Teitell
Journal:  Cell Cycle       Date:  2011-01-15       Impact factor: 4.534

3.  Tp53 deletion in B lineage cells predisposes mice to lymphomas with oncogenic translocations.

Authors:  M A W Rowh; A DeMicco; J E Horowitz; B Yin; K S Yang-Iott; A M Fusello; E Hobeika; M Reth; C H Bassing
Journal:  Oncogene       Date:  2011-05-30       Impact factor: 9.867

Review 4.  Unique and redundant functions of ATM and DNA-PKcs during V(D)J recombination.

Authors:  Eric J Gapud; Barry P Sleckman
Journal:  Cell Cycle       Date:  2011-06-15       Impact factor: 4.534

5.  A self-reinforcing regulatory network triggered by limiting IL-7 activates pre-BCR signaling and differentiation.

Authors:  Kyoko Ochiai; Mark Maienschein-Cline; Malay Mandal; Joseph R Triggs; Eric Bertolino; Roger Sciammas; Aaron R Dinner; Marcus R Clark; Harinder Singh
Journal:  Nat Immunol       Date:  2012-01-22       Impact factor: 25.606

6.  AID-induced genotoxic stress promotes B cell differentiation in the germinal center via ATM and LKB1 signaling.

Authors:  Mara H Sherman; Ali I Kuraishy; Chetan Deshpande; Jason S Hong; Nicholas A Cacalano; Richard A Gatti; John P Manis; Michael A Damore; Matteo Pellegrini; Michael A Teitell
Journal:  Mol Cell       Date:  2010-09-24       Impact factor: 17.970

Review 7.  The DNA-dependent protein kinase (DNA-PK): More than just a case of making ends meet?

Authors:  Richard Hill; Patrick W K Lee
Journal:  Cell Cycle       Date:  2010-09-15       Impact factor: 4.534

8.  Ataxia telangiectasia mutated (Atm) and DNA-PKcs kinases have overlapping activities during chromosomal signal joint formation.

Authors:  Eric J Gapud; Yair Dorsett; Bu Yin; Elsa Callen; Andrea Bredemeyer; Grace K Mahowald; Kazuo Q Omi; Laura M Walker; Jeffrey J Bednarski; Peter J McKinnon; Craig H Bassing; Andre Nussenzweig; Barry P Sleckman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-18       Impact factor: 11.205

9.  H2AX prevents CtIP-mediated DNA end resection and aberrant repair in G1-phase lymphocytes.

Authors:  Beth A Helmink; Anthony T Tubbs; Yair Dorsett; Jeffrey J Bednarski; Laura M Walker; Zhihui Feng; Girdhar G Sharma; Peter J McKinnon; Junran Zhang; Craig H Bassing; Barry P Sleckman
Journal:  Nature       Date:  2010-12-15       Impact factor: 49.962

10.  RAG-induced DNA double-strand breaks signal through Pim2 to promote pre-B cell survival and limit proliferation.

Authors:  Jeffrey J Bednarski; Andrew Nickless; Deepta Bhattacharya; Rupesh H Amin; Mark S Schlissel; Barry P Sleckman
Journal:  J Exp Med       Date:  2011-12-26       Impact factor: 14.307

View more
  6 in total

Review 1.  Novel molecular mechanism for generating NK-cell fitness and memory.

Authors:  Jenny M Karo; Joseph C Sun
Journal:  Eur J Immunol       Date:  2015-06-24       Impact factor: 5.532

2.  Peripheral subnuclear positioning suppresses Tcrb recombination and segregates Tcrb alleles from RAG2.

Authors:  Elizabeth A W Chan; Grace Teng; Elizabeth Corbett; Kingshuk Roy Choudhury; Craig H Bassing; David G Schatz; Michael S Krangel
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

3.  Promoter Hypermethylation of the ATM Gene as a Novel Biomarker for Breast Cancer

Authors:  Nasrin Begam; Kaiser Jamil; Suryanarayana G Raju
Journal:  Asian Pac J Cancer Prev       Date:  2017-11-26

4.  DN2 Thymocytes Activate a Specific Robust DNA Damage Response to Ionizing Radiation-Induced DNA Double-Strand Breaks.

Authors:  Irene Calvo-Asensio; Tara Sugrue; Nabil Bosco; Antonius Rolink; Rhodri Ceredig
Journal:  Front Immunol       Date:  2018-06-11       Impact factor: 7.561

5.  Radiosensitivity in patients affected by ARPC1B deficiency: a new disease trait?

Authors:  Maria Chiriaco; Giorgiana Madalina Ursu; Donato Amodio; Nicola Cotugno; Stefano Volpi; Francesco Berardinelli; Simone Pizzi; Cristina Cifaldi; Matteo Zoccolillo; Ignazia Prigione; Silvia Di Cesare; Carmela Giancotta; Elisa Anastasio; Beatrice Rivalta; Lucia Pacillo; Paola Zangari; Alessandro G Fiocchi; Andrea Diociaiuti; Alessandro Bruselles; Francesca Pantaleoni; Andrea Ciolfi; Valentina D'Oria; Giuseppe Palumbo; Marco Gattorno; Maya El Hachem; Jean-Pierre de Villartay; Andrea Finocchi; Paolo Palma; Paolo Rossi; Marco Tartaglia; Alessandro Aiuti; Antonio Antoccia; Gigliola Di Matteo; Caterina Cancrini
Journal:  Front Immunol       Date:  2022-07-29       Impact factor: 8.786

Review 6.  Rare Genetic Diseases with Defects in DNA Repair: Opportunities and Challenges in Orphan Drug Development for Targeted Cancer Therapy.

Authors:  Sonali Bhattacharjee; Saikat Nandi
Journal:  Cancers (Basel)       Date:  2018-09-01       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.